Pivotal Study for Validation of Philips Dx (PDx)

CompletedOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

September 30, 2016

Conditions
Pathologic Processes
Trial Locations (4)

20904

Shady Grove Adventist, Silver Spring

22908

University of Virginia, Charlottesville

44195

Cleveland Clinic, Cleveland

75039

Miraca Life Sciences, Irving

All Listed Sponsors
lead

Philips Digital & Computational Pathology

INDUSTRY

NCT02529137 - Pivotal Study for Validation of Philips Dx (PDx) | Biotech Hunter | Biotech Hunter